
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $148.7M | $226.9M | $256.4M | $267M | $291.3M | |
Revenue Growth (YoY) | 30.63% | 52.55% | 12.99% | 4.15% | 9.08% | |
Cost of Revenues | $41.2M | $58.3M | $81.5M | $99.2M | $101M | |
Gross Profit | $107.6M | $168.6M | $174.9M | $167.8M | $190.2M | |
Gross Profit Margin | 72.31% | 74.3% | 68.21% | 62.84% | 65.31% | |
R&D Expenses | $12.3M | $15.9M | $20.8M | $26.7M | $33.3M | |
Selling, General & Admin | $63.6M | $93.9M | $113.5M | $139M | $153M | |
Other Inc / (Exp) | -$712K | $5.7M | -$5.3M | -$359K | $5.4M | |
Operating Expenses | $75.8M | $109.8M | $134.3M | $165.7M | $186.3M | |
Operating Income | $31.8M | $58.8M | $40.5M | $2M | $3.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $31.6M | $64.8M | $37.5M | $10.5M | $17.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $5M | $8.2M | $8.8M | $1.6M | $5.3M | |
Net Income to Company | $26.6M | $56.6M | $28.7M | $8.9M | $12.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $26.6M | $56.6M | $28.7M | $8.9M | $12.5M | |
Basic EPS (Cont. Ops) | $0.51 | $1.13 | $0.55 | $0.17 | $0.25 | |
Diluted EPS (Cont. Ops) | $0.46 | $1.00 | $0.50 | $0.16 | $0.23 | |
Weighted Average Basic Share | $12.6M | $50.2M | $52.3M | $51.8M | $49.2M | |
Weighted Average Diluted Share | $17.1M | $56.6M | $56.9M | $56M | $54.3M | |
EBITDA | $47.5M | $81.9M | $74.8M | $46.8M | $49.3M | |
EBIT | $31.8M | $58.8M | $40.5M | $2M | $3.9M | |
Revenue (Reported) | $148.7M | $226.9M | $256.4M | $267M | $291.3M | |
Operating Income (Reported) | $31.8M | $58.8M | $40.5M | $2M | $3.9M | |
Operating Income (Adjusted) | $31.8M | $58.8M | $40.5M | $2M | $3.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $43.6M | $54.6M | $55.4M | $66.7M | $63.8M | |
Revenue Growth (YoY) | 53.83% | 25.1% | 1.57% | 20.38% | -4.31% | |
Cost of Revenues | $12.3M | $18M | $23.9M | $25.4M | $25.6M | |
Gross Profit | $31.3M | $36.6M | $31.5M | $41.3M | $38.2M | |
Gross Profit Margin | 71.79% | 67.02% | 56.93% | 61.88% | 59.91% | |
R&D Expenses | $3.7M | $4.8M | $6.5M | $8M | $8.8M | |
Selling, General & Admin | $20.9M | $27.2M | $35.7M | $38.8M | $41.4M | |
Other Inc / (Exp) | $137K | $1.5M | -$465K | $258K | -$1M | |
Operating Expenses | $24.7M | $32M | $42.2M | $46.8M | $50.1M | |
Operating Income | $6.6M | $4.6M | -$10.7M | -$5.5M | -$11.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $6.8M | $6.2M | -$9.2M | -$2.7M | -$11.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.9M | $1.4M | -$3.4M | -$249K | -$1.8M | |
Net Income to Company | $4.9M | $4.8M | -$5.9M | -$2.5M | -$9.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $4.9M | $4.8M | -$5.9M | -$2.5M | -$9.5M | |
Basic EPS (Cont. Ops) | $0.10 | $0.09 | -$0.11 | -$0.05 | -$0.20 | |
Diluted EPS (Cont. Ops) | $0.09 | $0.08 | -$0.11 | -$0.05 | -$0.20 | |
Weighted Average Basic Share | $49.1M | $51.9M | $52.7M | $50M | $48.3M | |
Weighted Average Diluted Share | $56.8M | $56.9M | $52.7M | $50M | $48.3M | |
EBITDA | $11.2M | $11.8M | $760K | $5.7M | -$227K | |
EBIT | $6.6M | $4.6M | -$10.7M | -$5.5M | -$11.9M | |
Revenue (Reported) | $43.6M | $54.6M | $55.4M | $66.7M | $63.8M | |
Operating Income (Reported) | $6.6M | $4.6M | -$10.7M | -$5.5M | -$11.9M | |
Operating Income (Adjusted) | $6.6M | $4.6M | -$10.7M | -$5.5M | -$11.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $164M | $237.9M | $257.2M | $278.3M | $288.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $43.4M | $64M | $87.4M | $100.8M | $101.2M | |
Gross Profit | $120.6M | $173.8M | $169.9M | $177.5M | $187.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $13.1M | $16.9M | $22.6M | $28.2M | $34.1M | |
Selling, General & Admin | $70.1M | $100.2M | $122M | $142.2M | $155.6M | |
Other Inc / (Exp) | -$589K | $7M | -$7.2M | $364K | $4.1M | |
Operating Expenses | $83.2M | $117.1M | $144.6M | $170.3M | $189.6M | |
Operating Income | $37.4M | $56.7M | $25.3M | $7.2M | -$2.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $37.1M | $64.1M | $22M | $17M | $9.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $6.5M | $7.7M | $4M | $4.8M | $3.7M | |
Net Income to Company | $30.6M | $56.5M | $18.1M | $12.3M | $5.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $30.6M | $56.5M | $18.1M | $12.3M | $5.5M | |
Basic EPS (Cont. Ops) | $0.62 | $1.11 | $0.34 | $0.24 | $0.11 | |
Diluted EPS (Cont. Ops) | $0.56 | $1.00 | $0.31 | $0.21 | $0.08 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $54.1M | $82.4M | $63.8M | $51.7M | $43.4M | |
EBIT | $37.4M | $56.7M | $25.3M | $7.2M | -$2.5M | |
Revenue (Reported) | $164M | $237.9M | $257.2M | $278.3M | $288.4M | |
Operating Income (Reported) | $37.4M | $56.7M | $25.3M | $7.2M | -$2.5M | |
Operating Income (Adjusted) | $37.4M | $56.7M | $25.3M | $7.2M | -$2.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $43.6M | $54.6M | $55.4M | $66.7M | $63.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $12.3M | $18M | $23.9M | $25.4M | $25.6M | |
Gross Profit | $31.3M | $36.6M | $31.5M | $41.3M | $38.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $3.7M | $4.8M | $6.5M | $8M | $8.8M | |
Selling, General & Admin | $20.9M | $27.2M | $35.7M | $38.8M | $41.4M | |
Other Inc / (Exp) | $137K | $1.5M | -$465K | $258K | -$1M | |
Operating Expenses | $24.7M | $32M | $42.2M | $46.8M | $50.1M | |
Operating Income | $6.6M | $4.6M | -$10.7M | -$5.5M | -$11.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $6.8M | $6.2M | -$9.2M | -$2.7M | -$11.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.9M | $1.4M | -$3.4M | -$249K | -$1.8M | |
Net Income to Company | $4.9M | $4.8M | -$5.9M | -$2.5M | -$9.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $4.9M | $4.8M | -$5.9M | -$2.5M | -$9.5M | |
Basic EPS (Cont. Ops) | $0.10 | $0.09 | -$0.11 | -$0.05 | -$0.20 | |
Diluted EPS (Cont. Ops) | $0.09 | $0.08 | -$0.11 | -$0.05 | -$0.20 | |
Weighted Average Basic Share | $49.1M | $51.9M | $52.7M | $50M | $48.3M | |
Weighted Average Diluted Share | $56.8M | $56.9M | $52.7M | $50M | $48.3M | |
EBITDA | $11.2M | $11.8M | $760K | $5.7M | -$227K | |
EBIT | $6.6M | $4.6M | -$10.7M | -$5.5M | -$11.9M | |
Revenue (Reported) | $43.6M | $54.6M | $55.4M | $66.7M | $63.8M | |
Operating Income (Reported) | $6.6M | $4.6M | -$10.7M | -$5.5M | -$11.9M | |
Operating Income (Adjusted) | $6.6M | $4.6M | -$10.7M | -$5.5M | -$11.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $81.2M | $82.5M | $92.4M | $78.5M | $100.5M | |
Short Term Investments | $19.8M | $77.1M | $82M | $96.8M | $40.1M | |
Accounts Receivable, Net | $219.5M | $286.9M | $314.3M | $375.5M | $424.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $6.6M | $14.2M | $14.8M | $11.1M | $10.1M | |
Total Current Assets | $327.1M | $460.7M | $503.5M | $562M | $575.5M | |
Property Plant And Equipment | $30M | $71.8M | $97.4M | $81.8M | $102.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $6.3M | $6.3M | $29.6M | $29.6M | $29.6M | |
Other Intangibles | -- | -- | $8.3M | $5.9M | $4.3M | |
Other Long-Term Assets | $7.1M | $10.9M | $2.4M | $2.1M | $2.3M | |
Total Assets | $371.2M | $550.2M | $642.2M | $695.2M | $739.5M | |
Accounts Payable | $176.7M | $244.3M | $277.4M | $347.7M | $386.6M | |
Accrued Expenses | $1.5M | $1.5M | $4.3M | $6.9M | $6.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $3.9M | $5.7M | $6.2M | $5.8M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $191.6M | $267M | $302M | $379.6M | $418.8M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $195.8M | $293M | $330M | $399M | $462.3M | |
Common Stock | $6K | $6K | $6K | $6K | $6K | |
Other Common Equity Adj | $1K | -$36K | -$9K | -$4K | -$636K | |
Common Equity | $175.4M | $257.2M | $312.2M | $296.2M | $277.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $175.4M | $257.2M | $312.2M | $296.2M | $277.3M | |
Total Liabilities and Equity | $371.2M | $550.2M | $642.2M | $695.2M | $739.5M | |
Cash and Short Terms | $101M | $159.6M | $174.4M | $175.3M | $140.6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $76.6M | $74.5M | $79.3M | $80.2M | $101.8M | |
Short Term Investments | $33.4M | $100.3M | $93.9M | $93.9M | $42.3M | |
Accounts Receivable, Net | $173.1M | $218.4M | $253M | $303.3M | $349.1M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $8M | $11.8M | $14.2M | $11.5M | $12M | |
Total Current Assets | $291.1M | $404.9M | $440.3M | $488.9M | $505.3M | |
Property Plant And Equipment | $34M | $71.8M | $93.4M | $80M | $97M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $6.3M | $6.3M | $29.6M | $29.6M | $29.6M | |
Other Intangibles | -- | -- | $7M | $5.5M | $3.9M | |
Other Long-Term Assets | $1.7M | $12.6M | $2.2M | $3.7M | $3.3M | |
Total Assets | $333.5M | $497.6M | $577.5M | $626.2M | $668.6M | |
Accounts Payable | $136M | $186M | $222.6M | $289.2M | $323.6M | |
Accrued Expenses | $3M | $3.1M | $9.4M | $8.4M | $9.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $3.9M | $5.7M | $6.8M | $6.2M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $145.3M | $200.6M | $247.6M | $315.8M | $350.2M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $149.4M | $229.9M | $271.1M | $337.5M | $393M | |
Common Stock | $6K | $6K | $6K | $6K | $6K | |
Other Common Equity Adj | -- | -$239K | $8K | -$25K | -$366K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $184.1M | $267.7M | $306.4M | $288.7M | $275.6M | |
Total Liabilities and Equity | $333.5M | $497.6M | $577.5M | $626.2M | $668.6M | |
Cash and Short Terms | $110M | $174.7M | $173.2M | $174.1M | $144.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $26.6M | $56.6M | $28.7M | $8.9M | $12.5M | |
Depreciation & Amoritzation | $15.7M | $23.1M | $34.2M | $44.8M | $45.4M | |
Stock-Based Compensation | $3.6M | $14.1M | $20.6M | $28.9M | $37.7M | |
Change in Accounts Receivable | -$102.2M | -$67.4M | -$24.4M | -$75.7M | -$49.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $24.3M | $88.7M | $87.2M | $81.1M | $73.4M | |
Capital Expenditures | $31.4M | $39.4M | $48.9M | $28.3M | $38.5M | |
Cash Acquisitions | -- | -- | -$28.1M | -- | -- | |
Cash From Investing | -$29.9M | -$96.7M | -$81.4M | -$39M | $22.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$10K | -$119K | -$126K | -$131K | |
Repurchase of Common Stock | -$3K | -$858K | -- | -$59.3M | -$75.3M | |
Other Financing Activities | $4.3M | -- | -- | -- | -$2.1M | |
Cash From Financing | $52.5M | $9.4M | $4M | -$56M | -$73.5M | |
Beginning Cash (CF) | $34.3M | $81.2M | $82.5M | $92.4M | $78.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $46.9M | $1.3M | $9.9M | -$13.9M | $22.3M | |
Ending Cash (CF) | $81.2M | $82.5M | $92.4M | $78.5M | $100.5M | |
Levered Free Cash Flow | -$7.1M | $49.3M | $38.3M | $52.8M | $34.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $4.9M | $4.8M | -$5.9M | -$2.5M | -$9.5M | |
Depreciation & Amoritzation | $4.6M | $7.2M | $11.4M | $11.2M | $11.7M | |
Stock-Based Compensation | $3.2M | $5.1M | $7.1M | $9.1M | $9.7M | |
Change in Accounts Receivable | $46.4M | $68.6M | $61.3M | $72.2M | $75.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $12.7M | $19.3M | $12.8M | $24.3M | $15.6M | |
Capital Expenditures | $3.3M | $4.4M | $7.4M | $8M | $8.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$16.8M | -$27.8M | -$18.3M | -$3.9M | -$10.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$28K | -$31K | -$32K | -$35K | |
Repurchase of Common Stock | -$27K | -- | -$7.9M | -$17.5M | -$5M | |
Other Financing Activities | -$805K | -- | -- | -$2.1M | -- | |
Cash From Financing | -$381K | $453K | -$7.6M | -$18.7M | -$4.5M | |
Beginning Cash (CF) | $81.2M | $82.5M | $92.4M | $78.5M | $100.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | $279K | |
Additions / Reductions | -$4.5M | -$8M | -$13.1M | $1.7M | $1.1M | |
Ending Cash (CF) | $76.6M | $74.5M | $79.3M | $80.2M | $101.8M | |
Levered Free Cash Flow | $9.4M | $14.9M | $5.3M | $16.3M | $7.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $30.6M | $56.5M | $18.1M | $12.3M | $5.5M | |
Depreciation & Amoritzation | $16.7M | $25.7M | $38.5M | $44.6M | $45.8M | |
Stock-Based Compensation | $6.2M | $16.1M | $22.6M | $30.9M | $38.3M | |
Change in Accounts Receivable | -$88.2M | -$45.3M | -$31.7M | -$64.8M | -$45.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $22.3M | $95.3M | $80.7M | $92.7M | $64.8M | |
Capital Expenditures | $30.7M | $40.5M | $51.9M | $28.9M | $38.8M | |
Cash Acquisitions | -- | -- | -$28.1M | -- | -- | |
Cash From Investing | -$46.9M | -$107.7M | -$71.8M | -$24.6M | $16.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$38K | -$122K | -$127K | -$134K | |
Repurchase of Common Stock | -$30K | -$831K | -$7.9M | -$68.9M | -$62.8M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $52M | $10.2M | -$4M | -$67.1M | -$59.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $27.5M | -$2.2M | $4.8M | $934K | $21.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$8.4M | $54.8M | $28.7M | $63.8M | $25.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $4.9M | $4.8M | -$5.9M | -$2.5M | -$9.5M | |
Depreciation & Amoritzation | $4.6M | $7.2M | $11.4M | $11.2M | $11.7M | |
Stock-Based Compensation | $3.2M | $5.1M | $7.1M | $9.1M | $9.7M | |
Change in Accounts Receivable | $46.4M | $68.6M | $61.3M | $72.2M | $75.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $12.7M | $19.3M | $12.8M | $24.3M | $15.6M | |
Capital Expenditures | $3.3M | $4.4M | $7.4M | $8M | $8.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$16.8M | -$27.8M | -$18.3M | -$3.9M | -$10.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$28K | -$31K | -$32K | -$35K | |
Repurchase of Common Stock | -$27K | -- | -$7.9M | -$17.5M | -$5M | |
Other Financing Activities | -$805K | -- | -- | -$2.1M | -- | |
Cash From Financing | -$381K | $453K | -$7.6M | -$18.7M | -$4.5M | |
Beginning Cash (CF) | $81.2M | $82.5M | $92.4M | $78.5M | $100.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | $279K | |
Additions / Reductions | -$4.5M | -$8M | -$13.1M | $1.7M | $1.1M | |
Ending Cash (CF) | $76.6M | $74.5M | $79.3M | $80.2M | $101.8M | |
Levered Free Cash Flow | $9.4M | $14.9M | $5.3M | $16.3M | $7.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.